# ClinicalTrials.gov record NCT07411560

> PeptideScanner retained ClinicalTrials.gov record NCT07411560 at 2026-07-30T16:20:49.304Z. Its registry update date was 2026-04-13, and PeptideScanner's reviewed identity mapping was cagrilintide.

- Evidence object: `story:clinicaltrials-gov-nct07411560-cagrilintide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-04-13
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-09-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct07411560-cagrilintide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct07411560-cagrilintide-v1.json
- Content SHA-256: `cc2faea48279e4667ec5d7ce129d490bab84fe5957ddec550619f9787a573b61`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT07411560 ([`ctg-observation-nct07411560-2026-04-13-91c9774e2665`](#source-ctg-observation-nct07411560-2026-04-13-91c9774e2665))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT07411560 at 2026-07-30T16:20:49.304Z. Its registry update date was 2026-04-13, and PeptideScanner's reviewed identity mapping was cagrilintide. ([`ctg-observation-nct07411560-2026-04-13-91c9774e2665`](#source-ctg-observation-nct07411560-2026-04-13-91c9774e2665))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT07411560 at 2026-07-30T16:20:49.304Z. Its registry update date was 2026-04-13, and PeptideScanner's reviewed identity mapping was cagrilintide. ([`ctg-observation-nct07411560-2026-04-13-91c9774e2665`](#source-ctg-observation-nct07411560-2026-04-13-91c9774e2665))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct07411560-2026-04-13-91c9774e2665`](#source-ctg-observation-nct07411560-2026-04-13-91c9774e2665))

## Sources

<a id="source-ctg-observation-nct07411560-2026-04-13-91c9774e2665"></a>
- **ClinicalTrials.gov record NCT07411560 · retained source version 2026-04-13:91c9774e26650a98efe4c85261994552545bf520b1755f03c277d6d09713b523** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT07411560) (`ctg-observation-nct07411560-2026-04-13-91c9774e2665`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT07411560." Version 1, published 2026-09-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct07411560-cagrilintide-v1.json SHA-256: cc2faea48279e4667ec5d7ce129d490bab84fe5957ddec550619f9787a573b61.